Left ventricular assist device unloading effects on myocardial structure and function: Current status of the field and call for action

Current Opinion in Cardiology

Volumn 26, Issue 3, 2011, Pages 245-255

  Drakos, Stavros G ^a,b,c,d,e   Kfoury, Abdallah G ^a,b,c   Selzman, Craig H ^a,b   Verma, Divya Ratan ^a,b,c   Nanas, John N ^d   Li, Dean Y ^b   Stehlik, Josef ^a,b  

^a UTAH Cardiac Transplant Program   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c INTERMOUNTAIN MEDICAL CENTER   (United States)

^d UNIVERSITY OF ATHENS   (Greece)

^e UNIVERSITY OF UTAH   (United States)

Author keywords

heart failure; left ventricular assist device; myocardial recovery; remodeling

Indexed keywords

ADRENERGIC ACTIVITY; ARTICLE; ELECTROPHYSIOLOGY; EXTRACELLULAR MATRIX; HEART ARRHYTHMIA; HEART ASSIST DEVICE; HEART FAILURE; HEART FUNCTION; HEART INNERVATION; HEART LEFT VENTRICLE ASSIST DEVICE; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HUMAN; MICROVASCULATURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

CARDIOMEGALY; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FIBROSIS; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; MICROVESSELS; MYOCARDIUM; MYOCYTES, CARDIAC; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR REMODELING;

EID: 79955050634     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328345af13     Document Type: Article

References (121)

1. Katz AM. Maladaptive growth in the failing heart: the cardiomyopathy of overload. Cardiovasc Drugs Ther 2002; 16:245-249. (Pubitemid 35398626)
2. Soppa GK, Barton PJ, Terracciano CM, et al. Left ventricular assist deviceinduced molecular changes in the failing myocardium. Curr Opin Cardiol 2008; 23:206-218. (Pubitemid 351489323)
3. Klotz S, Jan Danser AH, Burkhoff D. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process. Prog Biophys Mol Biol 2008; 97:479-496.
4. Drakos SG, Terrovitis JV, Anastasiou-Nana MI, et al. Reverse remodeling during long-term mechanical unloading of the left ventricle. J Mol Cell Cardiol 2007; 43:231-242. (Pubitemid 47301931)
5. Frazier OH, Radovancevic B, Abou-Awdi NL, et al. Ventricular remodeling after prolonged ventricular unloading 'heartrest' experience with the Heartmate left ventricular assist device [abstract]. J Heart Lung Transplant 1994; 13:77.
6. Maybaum S, Mancini D, Xydas S, et al. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 2007; 115:2497-2505. (Pubitemid 46763223)
7. Dandel M, Weng Y, Siniawski H, et al. Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy. Circulation 2008; 118:S94-S105.
8. Birks EJ, Tansley PD, Hardy J, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006; 355:1873-1884. (Pubitemid 44664645)
9. Birks EJ, George RS, Hedger M, et al. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation 2011; 123:381-390.
10. Drakos SG, Charitos EI, Nanas SN, et al. Ventricular-assist devices for the treatment of chronic heart failure. Expert Rev Cardiovasc Ther 2007; 5:571-584. (Pubitemid 46805583)
11. Dandel M, Weng Y, Siniawski H, et al. Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devices. Eur Heart J 2010. [Epub ahead of print]
12. Liden H, Karason K, Bergh CH, et al. The feasibility of left ventricular mechanical support as a bridge to cardiac recovery. Eur J Heart Fail 2007; 9:525-530. (Pubitemid 46562590)
13. Gorcsan J 3rd, Severyn D, Murali S, et al. Noninvasive assessment of myocardial recovery on chronic left ventricular assist device: results associated with successful device removal. J Heart Lung Transplant 2003; 22:1304-1313. (Pubitemid 37522033)
14. Matsumiya G, Monta O, Fukushima N, et al. Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy? J Thorac Cardiovasc Surg 2005; 130:699-704. (Pubitemid 41265707)
15. Simon MA, Primack BA, Teuteberg J, et al. Left ventricular remodeling and myocardial recovery on mechanical circulatory support. J Card Fail 2010; 16:99-105.
16. Farrar DJ, Holman WR, McBride LR, et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 2002; 21:516-521.
17. Mancini DM, Beniaminovitz A, Levin H, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 1998; 98:2383-2389. (Pubitemid 28549781)
18. Yacoub MH. A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery. Eur Heart J 2001; 22:534-540. (Pubitemid 32625243)
19. Busch MC, Haap M, Kristen A, et al. Asymptomatic sustained ventricular fibrillation in a patient with left ventricular assist device. Ann Emerg Med 2011; 57:25-28.
20. Fang JC. Rise of the machines: left ventricular assist devices as permanent therapy for advanced heart failure. N Engl J Med 2009; 361:2282-2285.
21. Hill JA, Olson EN. Cardiac plasticity. N Engl J Med 2008; 358:1370-1380.
22. Opie L, editor. Heart physiology. Philadelphia, PA: Lippincott Williams and Wilkins; 2004.
23. Opie LH, Commerford PJ, Gersh BJ, et al. Controversies in ventricular remodelling. Lancet 2006; 367:356-367. (Pubitemid 43151469)
24. Gerdes AM. Cardiac myocyte remodeling in hypertrophy and progression to failure. J Card Fail 2002; 8:S264-S268. (Pubitemid 36083069)
25. Nakatani S, McCarthy PM, Kottke-Marchant K, et al. Left ventricular echocardiographic and histologic changes: impact of chronic unloading by an implantable ventricular assist device. J Am Coll Cardiol 1996; 27:894-901.
26. Zafeiridis A, Jeevanandam V, Houser SR, et al. Regression of cellular hypertrophy after left ventricular assist device support. Circulation 1998; 98:656-662. (Pubitemid 28387492)
27. Kuhn M, Voss M, Mitko D, et al. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure. Cardiovasc Res 2004; 64:308-314. (Pubitemid 39361692)
28. Altemose GT, Gritsus V, Jeevanandam V, et al. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. J Heart Lung Transplant 1997; 16:765-773. (Pubitemid 27319153)
29. Razeghi P, Sharma S, Ying J, et al. Atrophic remodeling of the heart in vivo simultaneously activates pathways of protein synthesis and degradation. Circulation 2003; 108:2536-2541. (Pubitemid 37444418)
30. Thompson EW, Marino TA, Uboh CE, et al. Atrophy reversal and cardiocyte redifferentiation in reloaded cat myocardium. Circ Res 1984; 54:367-377. (Pubitemid 14143540)
31. Kinoshita M, Takano H, Takaichi S, et al. Influence of prolonged ventricular assistance on myocardial histopathology in intact heart. Ann Thorac Surg 1996; 61:640-645. (Pubitemid 26060894)
32. Oriyanhan W, Tsuneyoshi H, Nishina T, et al. Determination of optimal duration of mechanical unloading for failing hearts to achieve bridge to recovery in a rat heterotopic heart transplantation model. J Heart Lung Transplant 2007; 26:16-23. (Pubitemid 46096745)
33. Drakos SG, Kfoury AG, Hammond EH, et al. Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. J Am Coll Cardiol 2010; 56:382-391.
34. Jacquet L, Zerbe T, Stein KL, et al. Evolution of human cardiac myocyte dimension during prolonged mechanical support. J Thorac Cardiovasc Surg 1991; 101:256-259.
35. McNulty PH, Liu WX, Luba MC, et al. Effect of nonworking heterotopic transplantation on rat heart glycogen metabolism. Am J Physiol 1995; 268:E48-E54.
36. Rajabi M, Kassiotis C, Razeghi P, et al. Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev 2007; 12:331-343. (Pubitemid 350176706)
37. Wohlschlaeger J, Levkau B, Brockhoff G, et al. Hemodynamic support by left ventricular assist devices reduces cardiomyocyte DNA content in the failing human heart. Circulation 2010; 121:989-996.
38. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 1998; 83:1-14. (Pubitemid 28322094)
39. Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 2000; 101:2981-2988. (Pubitemid 30415891)
40. Villari B, Campbell SE, Hess OM, et al. Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease. J Am Coll Cardiol 1993; 22:1477-1484. (Pubitemid 23316376)
41. Lorell BH, Grossman W. Cardiac hypertrophy: the consequences for diastole. J Am Coll Cardiol 1987; 9:1189-1193. (Pubitemid 17065782)
42. Thohan V, Stetson SJ, Nagueh SF, et al. Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices. J Heart Lung Transplant 2005; 24:566-575. (Pubitemid 40693879)
43. Bruckner BA, Stetson SJ, Perez-Verdia A, et al. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant 2001; 20:457-464. (Pubitemid 32297756)
44. Akgul A, Skrabal CA, Thompson LO, et al. Role of mast cells and their mediators in failing myocardium under mechanical ventricular support. J Heart Lung Transplant 2004; 23:709-715. (Pubitemid 38721440)
45. Thompson LO, Skrabal CA, Loebe M, et al. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients. J Surg Res 2005; 123:25-32. (Pubitemid 40094641)
46. Liang H, Muller J, Weng YG, et al. Changes in myocardial collagen content before and after left ventricular assist device application in dilated cardiomyopathy. Chin Med J (Engl) 2004; 117:401-407. (Pubitemid 38444706)
47. Klotz S, Foronjy RF, Dickstein ML, et al. Mechanical unloading during left ventricular assist device support increases left ventricular collagen crosslinking and myocardial stiffness. Circulation 2005; 112:364-374. (Pubitemid 41022077)
48. Madigan JD, Barbone A, Choudhri AF, et al. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device. J Thorac Cardiovasc Surg 2001; 121:902-908.
49. McGowan BS, Scott CB, Mu A, et al. Unloading-induced remodeling in the normal and hypertrophic left ventricle. Am J Physiol Heart Circ Physiol 2003; 284:H2061-H2068. (Pubitemid 36622416)
50. Li YY, Feng Y, McTiernan CF, et al. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation 2001; 104:1147-1152. (Pubitemid 32830399)
51. Bruggink AH, van Oosterhout MF, de Jonge N, et al. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern. J Heart Lung Transplant 2006; 25:1091-1098. (Pubitemid 44311529)
52. Ho J, Parwani AV, Jukic DM, et al. Use of whole slide imaging in surgical pathology quality assurance: design and pilot validation studies. Hum Pathol 2006; 37:322-331. (Pubitemid 43277520)
53. Pots S. Angiogenesis measurement using digital pathology. Lab Medicine 2008; 39:265-271.
54. Virmani R, Burke A, Farb A, et al., editors. Cardiomyopathy. 2001 ed. Philadelphia, PA: Saunders Company; 2001.
55. James KB, McCarthy PM, Thomas JD, et al. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation 1995; 92:II191-II195.
56. Danser AH, van Kesteren CA, Bax WA, et al. Prorenin, renin, angiotensinogen, and angiotensin-converting enzyme in normal and failing human hearts. Evidence for renin binding. Circulation 1997; 96:220-226. (Pubitemid 27298424)
57. van Kesteren CA, van Heugten HA, Lamers JM, et al. Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. J Mol Cell Cardiol 1997; 29:2147-2157. (Pubitemid 27348525)
58. Klotz S, Burkhoff D, Garrelds IM, et al. The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin- aldosterone system: therapeutic consequences? Eur Heart J 2009; 30:805-812.
59. Klotz S, Danser AH, Foronjy RF, et al. The impact of angiotensin- converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure. J Am Coll Cardiol 2007; 49:1166-1174. (Pubitemid 46400328)
60. Campbell DJ, Kladis A, Duncan AM. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 1994; 23:439-449. (Pubitemid 24102039)
61. Tsagalou EP, Anastasiou-NanaM, Agapitos E, et al. Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2008; 52:1391-1398.
62. Hall JL, Grindle S, Han X, et al. Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. Physiol Genomics 2004; 17:283-291. (Pubitemid 38924173)
63. Rakusan K, Heron MI, Kolar F, et al. Transplantation-induced atrophy of normal and hypertrophic rat hearts: effect on cardiac myocytes and capillaries. J Mol Cell Cardiol 1997; 29:1045-1054. (Pubitemid 27196531)
64. Zhou AL, Egginton S, Brown MD, et al. Capillary growth in overloaded, hypertrophic adult rat skeletal muscle: an ultrastructural study. Anat Rec 1998; 252:49-63. (Pubitemid 28397561)
65. Wolf C, Cai WJ, Vosschulte R, et al. Vascular remodeling and altered protein expression during growth of coronary collateral arteries. J Mol Cell Cardiol 1998; 30:2291-2305. (Pubitemid 28549981)
66. Zeisberg EM, Tarnavski O, Zeisberg M, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007; 13:952-961. (Pubitemid 47222040)
67. Towbin JA. Scarring in the heart: a reversible phenomenon? N Engl J Med 2007; 357:1767-1768.
68. Whitehead KJ, Chan AC, Navankasattusas S, et al. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med 2009; 15:177-184.
69. Jones CA, London NR, Chen H, et al. Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat Med 2008; 14:448-453. (Pubitemid 351499393)
70. Wilson BD, Ii M, Park KW, et al. Netrins promote developmental and therapeutic angiogenesis. Science 2006; 313:640-644. (Pubitemid 44201136)
71. Hajjar RJ, Muller FU, Schmitz W, et al. Molecular aspects of adrenergic signal transduction in cardiac failure. J Mol Med 1998; 76:747-755. (Pubitemid 28475169)
72. Feldman DS, Elton TS, Sun B, et al. Mechanisms of disease: detrimental adrenergic signaling in acute decompensated heart failure. Nat Clin Pract Cardiovasc Med 2008; 5:208-218. (Pubitemid 351472165)
73. Brodde OE. Beta-adrenergic receptors in failing human myocardium. Basic Res Cardiol 1996; 91:35-40.
74. Bristow MR, Anderson FL, Port JD, et al. Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation 1991; 84:1024-1039.
75. Engelhardt S, Bohm M, Erdmann E, et al. Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure. J Am Coll Cardiol 1996; 27:146-154.
76. Morawietz H, Szibor M, Goettsch W, et al. Deloading of the left ventricle by ventricular assist device normalizes increased expression of endothelin ET(A) receptors but not endothelin-converting enzyme-1 in patients with end-stage heart failure. Circulation 2000; 102:III188-III193.
77. Dipla K, Mattiello JA, Jeevanandam V, et al. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 1998; 97:2316-2322. (Pubitemid 28280385)
78. Ogletree-Hughes ML, Stull LB, Sweet WE, et al. Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation 2001; 104:881-886. (Pubitemid 32778037)
79. Heerdt PM, Holmes JW, Cai B, et al. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation 2000; 102:2713-2719.
80. Hall JL, Birks EJ, Grindle S, et al. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J 2007; 28:613-627. (Pubitemid 47355497)
81. Drakos SG, Athanasoulis T, Malliaras KG, et al. Myocardial sympathetic innervation and long-term left ventricular mechanical unloading. JACC Cardiovasc Imaging 2010; 3:64-70.
82. Takeishi Y, Jalili T, Hoit BD, et al. Alterations in Ca2+ cycling proteins and G alpha q signaling after left ventricular assist device support in failing human hearts. Cardiovasc Res 2000; 45:883-888. (Pubitemid 30089650)
83. Rodrigue-Way A, Burkhoff D, Geesaman BJ, et al. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support. J Heart Lung Transplant 2005; 24:73-80. (Pubitemid 40093996)
84. Takaseya T, Ishimatsu M, Tayama E, et al. Mechanical unloading improves intracellular Ca2+ regulation in rats with doxorubicin-induced cardiomyopathy. J Am Coll Cardiol 2004; 44:2239-2246. (Pubitemid 39576045)
85. Klotz S, Barbone A, Reiken S, et al. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties. J Am Coll Cardiol 2005; 45:668-676. (Pubitemid 40278964)
86. Terracciano CM, Harding SE, Adamson D, et al. Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy. Eur Heart J 2003; 24:1329-1339. (Pubitemid 36917704)
87. Zaugg M, Xu W, Lucchinetti E, et al. Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 2000; 102:344-350. (Pubitemid 30457587)
88. Tevaearai HT, Eckhart AD, Walton GB, et al. Myocardial gene transfer and overexpression of beta2-adrenergic receptors potentiates the functional recovery of unloaded failing hearts. Circulation 2002; 106:124-129. (Pubitemid 34747452)
89. Burkhoff D, Flaherty JT, Yue DT, et al. In vitro studies of isolated supported human hearts. Heart Vessels 1988; 4:185-196. (Pubitemid 19186796)
90. Weiss RM KW. The impact of prolonged rotary ventricular assist device support upon ventricular geometry and flow kinetics. J Am Soc Echocardiogr 2010; 24:149-156.
91. Klotz S, Deng MC, Stypmann J, et al. Left ventricular pressure and volume unloading during pulsatile versus nonpulsatile left ventricular assist device support. Ann Thorac Surg 2004; 77:143-149; discussion 149-150. (Pubitemid 38130000)
92. Zimpfer D, Zrunek P, Roethy W, et al. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J Thorac Cardiovasc Surg 2007; 133:689-695.
93. Haft J, Armstrong W, Dyke DB, et al. Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices. Circulation 2007; 116:I8-15.
94. Garcia S, Kandar F, Boyle A, et al. Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventricular unloading. J Heart Lung Transplant 2008; 27:261-267. (Pubitemid 351384702)
95. Patel ND, Weiss ES, Schaffer J, et al. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile Heart- Mate I and axial-flow HeartMate II devices. Ann Thorac Surg 2008; 86:832- 840; discussion 832-840.
96. Welp H, Rukosujew A, Tjan TD, et al. Effect of pulsatile and nonpulsatile left ventricular assist devices on the renin-angiotensin system in patients with end-stage heart failure. Thorac Cardiovasc Surg 2010; 58 (Suppl 2):S185-S188.
97. Vatta M, Stetson SJ, Jimenez S, et al. Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices. J Am Coll Cardiol 2004; 43:811-817. (Pubitemid 38296481)
98. Loebe M, Koster A, Sanger S, et al. Inflammatory response after implantation of a left ventricular assist device: comparison between the axial flow Micro- Med DeBakey VAD and the pulsatile Novacor device. ASAIO J 2001; 47:272-274. (Pubitemid 32423018)
99. Drakos SG, Verma DR, Stehlik J, et al. Mechanical unloading with continuous- flow left ventricular assist devices: effects on left atrial remodeling. ISHLT 31st Annual Meeting & Scientific Session [abstract]. 2011.
100. Etz CD, Welp HA, Tjan TD, et al. Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices. Ann Thorac Surg 2007; 83:1697-1705. (Pubitemid 46616800)
101. John R, Liao K, Kamdar F, et al. Effects on pre and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices. J Thorac Cardiovasc Surg 2010; 140:447-452.
102. Santamore WP, Gray LA Jr. Left ventricular contributions to right ventricular systolic function during LVAD support. Ann Thorac Surg 1996; 61:350-356. (Pubitemid 26053537)
103. Kukucka M, Potapov E, Stepanenko A, et al. Acute impact of left ventricular unloading by left ventricular assist device on the right ventricle geometry and function: effect of nitric oxide inhalation. J Thorac Cardiovasc Surg 2010. [Epub ahead of print]
104. Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous- flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 2010; 29:S1-S39.
105. Nanas S, Nanas J, Kassiotis C, et al. Respiratory muscles performance is related to oxygen kinetics during maximal exercise and early recovery in patients with congestive heart failure. Circulation 1999; 100:503-508. (Pubitemid 29360159)
106. Meyer FJ, Borst MM, Zugck C, et al. Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation 2001; 103:2153-2158. (Pubitemid 32458324)
107. Dimopoulos SK, Drakos SG, Terrovitis JV, et al. Improvement in respiratory muscle dysfunction with continuous-flow left ventricular assist devices. J Heart Lung Transplant 2010; 29:906-908.
108. Xydas S, Rosen RS, Ng C, et al. Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery. J Heart Lung Transplant 2006; 25:7-15. (Pubitemid 43049658)
109. Harding JD, Piacentino V 3rd, Gaughan JP, et al. Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure. Circulation 2001; 104:1241-1247. (Pubitemid 32848112)
110. Drakos SG, Terrovitis JV, Nanas JN, et al. Reverse electrophysiologic remodeling after cardiac mechanical unloading for end-stage non-ischemic cardiomyopathy. Ann Thorac Surg 2011; 91:764-769.
111. Ziv O, Dizon J, Thosani A, et al. Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol 2005; 45:1428-1434. (Pubitemid 40615614)
112. Bedi M, Kormos R, Winowich S, et al. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol 2007; 99:1151-1153. (Pubitemid 46562514)
113. Oz MC, Rose EA, Slater J, et al. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. J Am Coll Cardiol 1994; 24:1688-1691. (Pubitemid 24369194)
114. Arai H, Swartz MT, Pennington DG, et al. Importance of ventricular arrhythmias in bridge patients with ventricular assist devices. ASAIO Trans 1991; 37:M427-M428.
115. Refaat M, Chemaly E, Lebeche D, et al. Ventricular arrhythmias after left ventricular assist device implantation. Pacing Clin Electrophysiol 2008; 31:1246-1252.
116. Maybaum S, Williams M, Barbone A, et al. Assessment of synchrony relationships between the native left ventricle and the HeartMate left ventricular assist device. J Heart Lung Transplant 2002; 21:509-515. (Pubitemid 34451023)
117. Drakos SG, Charitos CE, Ntalianis A, et al. Comparison of pulsatile with nonpulsatile mechanical support in a porcine model of profound cardiogenic shock. ASAIO J 2005; 51:26-29. (Pubitemid 40165247)
118. Terrovitis JV, Charitos CE, Tsolakis EJ, et al. Superior performance of a paraaortic counterpulsation device compared to the intraaortic balloon pump. World J Surg 2003; 27:1311-1316. (Pubitemid 37543026)
119. Meyns B, Klotz S, Simon A, et al. Proof of concept: hemodynamic response to long-term partial ventricular support with the synergy pocket micro-pump. J Am Coll Cardiol 2009; 54:79-86.
120. Malliaras KG, Terrovitis JV, Drakos SG, et al. Reverse cardiac remodeling enabled by mechanical unloading of the left ventricle. J Cardiovasc Transl Res 2009; 2:114-125.
121. Bruckner BA, Razeghi P, Stetson S, et al. Degree of cardiac fibrosis and hypertrophy at timeof implantation predicts myocardial improvement during left ventricular assist device support. J Heart Lung Transplant 2004; 23:36-42. (Pubitemid 38084828)